Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
System and method for content delivery
Use of cocoa extract
Devices including composite thermal capacitors
Soybean cultivar CL1013663
Communication system and data transmission method thereof
Blur correction device and imaging apparatus
Device to control force required to depress accelerator pedal
  Randomly Featured Patents
Electrode for electroslag remelting and process of producing alloy using the same
Packaging for multiple media discs and methods for making same
Flexible packaging apparatus and method
Series-resonant electronic ballast circuit
Seat with weight measuring capabilities
Circuit configuration for regulating the power consumption of an integrated circuit
Stuffed bendable doll
Alkyl aromatic isomerization process using a catalyst comprising a UZM-8HS composition
Antenna array
Direct detection of wireless interferers in a communication device for multiple modulation types